PTEN and nonpapillary renal cell carcinoma: Therefore, exploring the changes in various signaling pathways in patients with the PTEN mutation, and evaluating the significance in disease progression, will help us further understand the pathogenesis of the disease, providing more evidence for individualized treatment of ccRCC.